{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T05:12:21Z","timestamp":1778735541273,"version":"3.51.4"},"reference-count":77,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T00:00:00Z","timestamp":1778716800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T00:00:00Z","timestamp":1778716800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100020884","name":"Agencia Nacional de Investigaci\u00f3n y Desarrollo","doi-asserted-by":"publisher","award":["Convocatoria Nacional Subvenci\u00f3n a Instalaci\u00f3n en la Academia Convocatoria a\u00f1o 2021 Folio SA77210078"],"award-info":[{"award-number":["Convocatoria Nacional Subvenci\u00f3n a Instalaci\u00f3n en la Academia Convocatoria a\u00f1o 2021 Folio SA77210078"]}],"id":[{"id":"10.13039\/501100020884","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Comput Aided Mol Des"],"DOI":"10.1007\/s10822-026-00832-3","type":"journal-article","created":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T05:01:10Z","timestamp":1778734870000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Integrated computational modeling of chalcone-based inhibitors targeting carbonic anhydrase I and II: 3D-QSAR, molecular docking, and dynamics simulations"],"prefix":"10.1007","volume":"40","author":[{"given":"Mauricio","family":"Soto","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Cabezas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Felipe","family":"Stambuk","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cesar","family":"Gonz\u00e1lez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alison","family":"Acosta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marcos","family":"Lorca","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luis","family":"Espinoza","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katy","family":"D\u00edaz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andr\u00e9s F.","family":"Olea","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9577-5180","authenticated-orcid":false,"given":"Marco","family":"Mellado","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2434-8461","authenticated-orcid":false,"given":"Jaime","family":"Mella","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,5,14]]},"reference":[{"key":"832_CR1","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1038\/nrd2467","volume":"7","author":"CT Supuran","year":"2008","unstructured":"Supuran CT, Carbonic Anhydrases (2008) Novel therapeutic applications for inhibitors and activators. Nat Rev Drug Discovery 7:168\u2013181. https:\/\/doi.org\/10.1038\/nrd2467","journal-title":"Nat Rev Drug Discovery"},{"key":"832_CR2","doi-asserted-by":"publisher","first-page":"345","DOI":"10.3109\/14756366.2015.1122001","volume":"31","author":"CT Supuran","year":"2016","unstructured":"Supuran CT (2016) How many carbonic anhydrase inhibition mechanisms exist? J Enzyme Inhib Med Chem 31:345\u2013360. https:\/\/doi.org\/10.3109\/14756366.2015.1122001","journal-title":"J Enzyme Inhib Med Chem"},{"key":"832_CR3","doi-asserted-by":"publisher","first-page":"4421","DOI":"10.1021\/cr200176r","volume":"112","author":"V Alterio","year":"2012","unstructured":"Alterio V, Di Fiore A, D\u2019Ambrosio K, Supuran CT, De Simone G (2012) Multiple binding modes of inhibitors to carbonic anhydrases: how to design specific drugs targeting 15 different isoforms? Chem Rev 112:4421\u20134468. https:\/\/doi.org\/10.1021\/cr200176r","journal-title":"Chem Rev"},{"key":"832_CR4","doi-asserted-by":"publisher","first-page":"7697","DOI":"10.1002\/anie.200701189","volume":"46","author":"K Koehler","year":"2007","unstructured":"Koehler K, Hillebrecht A, Wischeler JS, Innocenti A, Heine A, Supuran CT, Klebe G (2007) Saccharin inhibits carbonic anhydrases:: possible explanation for its unpleasant metallic aftertaste. Angew Chem -Int Edit 46:7697\u20137699. https:\/\/doi.org\/10.1002\/anie.200701189","journal-title":"Angew Chem -Int Edit"},{"key":"832_CR5","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1080\/14756360009040695","volume":"15","author":"CT Supuran","year":"2000","unstructured":"Supuran CT, Scozzafava A, Ilies MA, Briganti F (2000) Carbonic anhydrase inhibitors:synthesis of sulfonamides incorporating 2,4,6-trisubstituted-pyridinium-ethylcarboxamido moieties possessing membrane-impermeability and in vivo selectivity for the membrane-bound (CA IV) versus the cytosolic (CA I and CA II) isozymes. J Enzym Inhib 15:381\u2013401. https:\/\/doi.org\/10.1080\/14756360009040695","journal-title":"J Enzym Inhib"},{"key":"832_CR6","doi-asserted-by":"publisher","first-page":"111600","DOI":"10.1016\/j.ejmech.2019.111600","volume":"182","author":"M Bozdag","year":"2019","unstructured":"Bozdag M, Ferraroni M, Ward C, Carta F, Bua S, Angeli A, Langdon SP, Kunkler IH, Al-Tamimi AMS, Supuran CT (2019) Carbonic anhydrase inhibitors based on sorafenib scaffold: design, synthesis, crystallographic investigation and effects on primary breast cancer cells. Eur J Med Chem 182:111600. https:\/\/doi.org\/10.1016\/j.ejmech.2019.111600","journal-title":"Eur J Med Chem"},{"key":"832_CR7","doi-asserted-by":"publisher","first-page":"20299","DOI":"10.1074\/jbc.M109.006478","volume":"284","author":"P Swietach","year":"2009","unstructured":"Swietach P, Patiar S, Supuran CT, Harris AL, Vaughan-Jones RD (2009) The role of carbonic anhydrase 9 in regulating extracellular and intracellular pH in three-dimensional tumor cell growths. J Biol Chem 284:20299\u201320310. https:\/\/doi.org\/10.1074\/jbc.M109.006478","journal-title":"J Biol Chem"},{"key":"832_CR8","doi-asserted-by":"publisher","first-page":"4691","DOI":"10.1021\/jm400414j","volume":"56","author":"F Carta","year":"2013","unstructured":"Carta F, Akdemir A, Scozzafava A, Masini E, Supuran CT (2013) Xanthates and trithiocarbonates strongly inhibit carbonic anhydrases and show antiglaucoma effects in vivo. J Med Chem 56:4691\u20134700. https:\/\/doi.org\/10.1021\/jm400414j","journal-title":"J Med Chem"},{"key":"832_CR9","doi-asserted-by":"publisher","first-page":"103557","DOI":"10.1016\/j.bioorg.2019.103557","volume":"95","author":"S Ghorai","year":"2020","unstructured":"Ghorai S, Pulya S, Ghosh K, Panda P, Ghosh B, Gayen S (2020) Structure-activity relationship of human carbonic anhydrase-II inhibitors: detailed insight for future development as anti-glaucoma agents. Bioorg Chem 95:103557. https:\/\/doi.org\/10.1016\/j.bioorg.2019.103557","journal-title":"Bioorg Chem"},{"key":"832_CR10","doi-asserted-by":"publisher","first-page":"2103","DOI":"10.1007\/s00044-022-02978-9","volume":"31","author":"V Goci\u0107","year":"2022","unstructured":"Goci\u0107 V, Markovi\u0107 A, Lazarevi\u0107 J (2022) The potential of chalcone derivatives as human carbonic anhydrase inhibitors in the therapy of glaucoma. Med Chem Res 31:2103\u20132118. https:\/\/doi.org\/10.1007\/s00044-022-02978-9","journal-title":"Med Chem Res"},{"key":"832_CR11","doi-asserted-by":"publisher","first-page":"35769","DOI":"10.1039\/d4ra06290f","volume":"14","author":"N Naeem","year":"2024","unstructured":"Naeem N, Sadiq A, Othman GA, Yassin HM, Mughal EU (2024) Exploring heterocyclic scaffolds in carbonic anhydrase inhibition: a decade of structural and therapeutic insights. RSC Adv 14:35769\u201335970. https:\/\/doi.org\/10.1039\/d4ra06290f","journal-title":"RSC Adv"},{"key":"832_CR12","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1038\/s41589-024-01762-7","volume":"21","author":"A Lopez","year":"2025","unstructured":"Lopez A, Siddiqi FH, Villeneuve J, Ureshino RP, Jeon H-Y, Koulousakis P, Keeling S, McEwan WA, Fleming A, Rubinsztein DC (2025) Carbonic anhydrase inhibition ameliorates tau toxicity via enhanced tau secretion. Nat Chem Biol 21:577\u2013587. https:\/\/doi.org\/10.1038\/s41589-024-01762-7","journal-title":"Nat Chem Biol"},{"key":"832_CR13","doi-asserted-by":"publisher","unstructured":"Provensi G, Carta F, Nocentini A, Supuran CT, Casamenti F, Passani MB, Fossati S (2019) A new kid on the block? Carbonic anhydrases as possible new targets in alzheimer\u2019s disease. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms20194724","DOI":"10.3390\/ijms20194724"},{"key":"832_CR14","doi-asserted-by":"publisher","first-page":"1","DOI":"10.2174\/157488410790410579","volume":"5","author":"D Batovska","year":"2010","unstructured":"Batovska D, Todorova I (2010) Trends in utilization of the pharmacological potential of chalcones. Curr Clin Pharmacol 5:1\u201329. https:\/\/doi.org\/10.2174\/157488410790410579","journal-title":"Curr Clin Pharmacol"},{"key":"832_CR15","doi-asserted-by":"publisher","first-page":"7762","DOI":"10.1021\/acs.chemrev.7b00020","volume":"117","author":"C Zhuang","year":"2017","unstructured":"Zhuang C, Zhang W, Sheng C, Zhang W, Xing C, Miao Z (2017) Chalcone: a privileged structure in medicinal chemistry. Chem Rev 117:7762\u20137810. https:\/\/doi.org\/10.1021\/acs.chemrev.7b00020","journal-title":"Chem Rev"},{"key":"832_CR16","doi-asserted-by":"publisher","first-page":"758","DOI":"10.1016\/j.ejmech.2014.08.033","volume":"85","author":"P Singh","year":"2014","unstructured":"Singh P, Anand A, Kumar V (2014) Recent developments in biological activities of chalcones: a mini review. Eur J Med Chem 85:758\u2013777. https:\/\/doi.org\/10.1016\/j.ejmech.2014.08.033","journal-title":"Eur J Med Chem"},{"key":"832_CR17","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/j.ejmech.2015.05.004","volume":"98","author":"DM Mahapatra","year":"2015","unstructured":"Mahapatra DM, Bharti SK, Asati V (2015) Anti-cancer chalcones: structural and molecular target perspectives. Eur J Med Chem 98:69\u2013114. https:\/\/doi.org\/10.1016\/j.ejmech.2015.05.004","journal-title":"Eur J Med Chem"},{"key":"832_CR18","doi-asserted-by":"publisher","first-page":"4410","DOI":"10.1080\/14786419.2021.1984465","volume":"36","author":"M Mellado","year":"2022","unstructured":"Mellado M, Reyna-Jeldes M, Weinstein-Oppenheimer C, Coddou C, Jara-Gutierrez C, Villena J, Aguilar LF (2022) Inhibition of Caco-2 and MCF-7 cancer cells using chalcones: synthesis, biological evaluation and computational study. Nat Prod Res 36:4410\u20134416. https:\/\/doi.org\/10.1080\/14786419.2021.1984465","journal-title":"Nat Prod Res"},{"key":"832_CR19","doi-asserted-by":"publisher","first-page":"4387","DOI":"10.3390\/molecules27144387","volume":"27","author":"L Bustos","year":"2022","unstructured":"Bustos L, Echiburu-Chau C, Castro-Alvarez A, Bradshaw B, Simirgiotis MJ, Mellado M, Parra C, Cuellar M (2022) Cytotoxic effects on breast cancer cell lines of chalcones derived from a natural precursor and their molecular docking analysis. Molecules 27:4387. https:\/\/doi.org\/10.3390\/molecules27144387","journal-title":"Molecules"},{"key":"832_CR20","doi-asserted-by":"publisher","first-page":"e2200042","DOI":"10.1002\/ardp.202200042","volume":"355","author":"M Mellado","year":"2022","unstructured":"Mellado M, Reyna-Jeldes M, Weinstein-Oppenheimer C, Covarrubias AA, Aguilar LF, Coddou C, Mella J, Cuellar MA (2022) QSAR-driven synthesis of antiproliferative chalcones against SH-SY5Y cancer cells: design, biological evaluation, and redesign. Arch Pharm 355:e2200042. https:\/\/doi.org\/10.1002\/ardp.202200042","journal-title":"Arch Pharm"},{"key":"832_CR21","doi-asserted-by":"publisher","first-page":"104681","DOI":"10.1016\/j.bioorg.2021.104681","volume":"108","author":"P Thapa","year":"2021","unstructured":"Thapa P, Upadhyay SP, Suo WZ, Singh V, Gurung P, Lee ES, Sharma R, Sharma M (2021) Chalcone and its analogs: therapeutic and diagnostic applications in alzheimer\u2019s disease. Bioorg Chem 108:104681. https:\/\/doi.org\/10.1016\/j.bioorg.2021.104681","journal-title":"Bioorg Chem"},{"key":"832_CR22","doi-asserted-by":"publisher","first-page":"104689","DOI":"10.1016\/j.bioorg.2021.104689","volume":"108","author":"M Mellado","year":"2021","unstructured":"Mellado M, Gonzalez C, Mella J, Aguilar LF, Vina D, Uriarte E, Cuellar M, Matos MJ (2021) Combined 3D-QSAR and docking analysis for the design and synthesis of chalcones as potent and selective monoamine oxidase B inhibitors. Bioorg Chem 108:104689. https:\/\/doi.org\/10.1016\/j.bioorg.2021.104689","journal-title":"Bioorg Chem"},{"key":"832_CR23","doi-asserted-by":"publisher","unstructured":"Mellado M, Salas CO, Uriarte E, Vina D, Jara-Gutierrez C, Matos MJ, Cuellar M, Design (2019) Synthesis and docking calculations of prenylated chalcones as selective monoamine oxidase B inhibitors with antioxidant activity. ChemistrySelect 4:7698\u20137703. https:\/\/doi.org\/10.1002\/slct.201901282","DOI":"10.1002\/slct.201901282"},{"key":"832_CR24","doi-asserted-by":"publisher","first-page":"5867","DOI":"10.1016\/j.bmcl.2016.11.017","volume":"26","author":"T Arslan","year":"2016","unstructured":"Arslan T, T\u00fcrko\u011flu EA, \u015eent\u00fcrk M, Supuran CT (2016) Synthesis and carbonic anhydrase inhibitory properties of novel chalcone substituted benzenesulfonamides. Bioorg Med Chem Lett 26:5867\u20135870. https:\/\/doi.org\/10.1016\/j.bmcl.2016.11.017","journal-title":"Bioorg Med Chem Lett"},{"key":"832_CR25","doi-asserted-by":"publisher","unstructured":"Tutar U, Ko\u00e7yi\u011fit \u00dcM, Gezegen H (2019) Evaluation of Antimicrobial, Antibiofilm and Carbonic Anhydrase Inhibition Profiles of 1,3-bis\u2010chalcone Derivatives. J Biochem Mol Toxicol. https:\/\/doi.org\/10.1002\/jbt.22281","DOI":"10.1002\/jbt.22281"},{"key":"832_CR26","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1016\/j.bioorg.2018.12.035","volume":"85","author":"S Burmaoglu","year":"2019","unstructured":"Burmaoglu S, Yilmaz AO, Polat MF, Kaya R, Gulcin \u0130, Algul O (2019) Synthesis and biological evaluation of novel Tris-chalcones as potent carbonic anhydrase, acetylcholinesterase, butyrylcholinesterase and \u03b1-glycosidase inhibitors. Bioorg Chem 85:191\u2013197. https:\/\/doi.org\/10.1016\/j.bioorg.2018.12.035","journal-title":"Bioorg Chem"},{"key":"832_CR27","doi-asserted-by":"publisher","DOI":"10.1007\/s11030-023-10774-9","author":"BO Aydin","year":"2024","unstructured":"Aydin BO, Anil DA, Demir Y, Alagoz MA, (2024) Organohalogen chalcones design, Synthesis, ADMET Prediction, Molecular Dynamics Study and Inhibition Effect on Acetylcholinesterase and Carbonic Anhydrase. Mol Diversity. https:\/\/doi.org\/10.1007\/s11030-023-10774-9","journal-title":"Mol Diversity"},{"key":"832_CR28","doi-asserted-by":"publisher","first-page":"1722","DOI":"10.1080\/14756366.2019.1670657","volume":"34","author":"S Bilginer","year":"2019","unstructured":"Bilginer S, Gul HI, Erdal FS, Sakagami H, Levent S, Gulcin I, Supuran CT, Synthesis (2019) Cytotoxicities, and carbonic anhydrase inhibition potential of 6-(3-Aryl-2-Propenoyl)-2(3H)-Benzoxazolones. J Enzyme Inhib Med Chem 34:1722\u20131729. https:\/\/doi.org\/10.1080\/14756366.2019.1670657","journal-title":"J Enzyme Inhib Med Chem"},{"key":"832_CR29","doi-asserted-by":"publisher","unstructured":"Stellenboom N (2019) Comparison of the inhibitory potential towards carbonic anhydrase, acetylcholinesterase and butyrylcholinesterase of chalcone and chalcone epoxide. J Biochem Mol Toxicol. https:\/\/doi.org\/10.1002\/jbt.22240","DOI":"10.1002\/jbt.22240"},{"key":"832_CR30","doi-asserted-by":"publisher","first-page":"634","DOI":"10.1080\/01480545.2018.1463242","volume":"42","author":"HE Aslan","year":"2019","unstructured":"Aslan HE, Demir Y, \u00d6zaslan MS, T\u00fcrkan F, Beydemir \u015e, K\u00fcfrevio\u011flu \u00d6I (2019) The behavior of some chalcones on acetylcholinesterase and carbonic anhydrase activity. Drug Chem Toxicol 42:634\u2013640. https:\/\/doi.org\/10.1080\/01480545.2018.1463242","journal-title":"Drug Chem Toxicol"},{"key":"832_CR31","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.ejmech.2013.04.035","volume":"66","author":"Z-C Wang","year":"2013","unstructured":"Wang Z-C, Qin Y-J, Wang P-F, Yang Y-A, Wen Q, Zhang X, Qiu H-Y, Duan Y-T, Wang Y-T, Sang Y-L et al (2013) Sulfonamides containing coumarin moieties selectively and potently inhibit carbonic anhydrases II and IX: design, synthesis, inhibitory activity and 3D-QSAR analysis. Eur J Med Chem 66:1\u201311. https:\/\/doi.org\/10.1016\/j.ejmech.2013.04.035","journal-title":"Eur J Med Chem"},{"key":"832_CR32","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1021\/ci600469w","volume":"47","author":"T Tuccinardi","year":"2007","unstructured":"Tuccinardi T, Nuti E, Ortore G, Supuran CT, Rossello A, Martinelli A (2007) Analysis of human carbonic anhydrase ii: docking reliability and receptor-based 3D-QSAR study. J Chem Inf Model 47:515\u2013525. https:\/\/doi.org\/10.1021\/ci600469w","journal-title":"J Chem Inf Model"},{"key":"832_CR33","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1021\/ci7002945","volume":"48","author":"A Hillebrecht","year":"2008","unstructured":"Hillebrecht A, Klebe G (2008) Use of 3D QSAR models for database screening: a feasibility study. J Chem Inf Model 48:384\u2013396. https:\/\/doi.org\/10.1021\/ci7002945","journal-title":"J Chem Inf Model"},{"key":"832_CR34","doi-asserted-by":"publisher","first-page":"688","DOI":"10.1080\/14756366.2016.1241781","volume":"32","author":"YE Heravi","year":"2017","unstructured":"Heravi YE, Sereshti H, Saboury AA, Ghasemi J, Amirmostofian M, Supuran CT (2017) 3D QSAR studies, pharmacophore modeling, and virtual screening of diarylpyrazole-benzenesulfonamide derivatives as a template to obtain new inhibitors, using human carbonic anhydrase II as a model protein. J Enzym Inhib Med Chem 32:688\u2013700. https:\/\/doi.org\/10.1080\/14756366.2016.1241781","journal-title":"J Enzym Inhib Med Chem"},{"key":"832_CR35","doi-asserted-by":"publisher","first-page":"1404","DOI":"10.1016\/j.bmc.2012.11.004","volume":"21","author":"L Tarko","year":"2013","unstructured":"Tarko L, Supuran CT (2013) QSAR studies of sulfamate and sulfamide inhibitors targeting human carbonic anhydrase isozymes I, II, IX and XII. Bioorg Med Chem 21:1404\u20131409. https:\/\/doi.org\/10.1016\/j.bmc.2012.11.004","journal-title":"Bioorg Med Chem"},{"key":"832_CR36","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1002\/cmdc.200600083","volume":"1","author":"A Hillebrecht","year":"2006","unstructured":"Hillebrecht A, Supuran CT, Klebe G (2006) Integrated approach using protein and ligand information to analyze selectivity- and affinity-determining features of carbonic anhydrase isozymes. ChemMedChem 1:839\u2013853. https:\/\/doi.org\/10.1002\/cmdc.200600083","journal-title":"ChemMedChem"},{"key":"832_CR37","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1016\/j.compbiolchem.2019.03.005","volume":"80","author":"Y Wang","year":"2019","unstructured":"Wang Y, Guo H, Tang G, He Q, Zhang Y, Hu Y, Wang Y, Lin ZA (2019) Selectivity study of benzenesulfonamide derivatives on human carbonic anhydrase II\/IX by 3D-QSAR, molecular docking and molecular dynamics simulation. Comput Biol Chem 80:234\u2013243. https:\/\/doi.org\/10.1016\/j.compbiolchem.2019.03.005","journal-title":"Comput Biol Chem"},{"key":"832_CR38","doi-asserted-by":"publisher","first-page":"3661","DOI":"10.3390\/ijms21103661","volume":"21","author":"MB Mikulova","year":"2020","unstructured":"Mikulova MB, Kruzlicova D, Pecher D, Supuran CT, Mikus P (2020) Synthetic strategies and computational inhibition activity study for triazinyl-substituted benzenesulfonamide conjugates with polar and hydrophobic amino acids as inhibitors of carbonic anhydrases. Int J Mol Sci 21:3661. https:\/\/doi.org\/10.3390\/ijms21103661","journal-title":"Int J Mol Sci"},{"key":"832_CR39","doi-asserted-by":"publisher","first-page":"6501","DOI":"10.1016\/j.bmc.2007.07.004","volume":"15","author":"J Singh","year":"2007","unstructured":"Singh J, Shaik B, Singh S, Sikhima S, Agrawal VK, Khadikar PV, Supuran CT (2007) QSAR studies on the activation of the human carbonic anhydrase cytosolic isoforms I and II and secretory isozyme VI with amino acids and amines. Bioorg Med Chem 15:6501\u20136509. https:\/\/doi.org\/10.1016\/j.bmc.2007.07.004","journal-title":"Bioorg Med Chem"},{"key":"832_CR40","doi-asserted-by":"publisher","first-page":"30","DOI":"10.2174\/157340608783331461","volume":"4","author":"J Singh","year":"2008","unstructured":"Singh J, Singh S, Mishra R, Khadikar PV, Supuran CT, Clare BW, Lakhwani M (2008) Estimation of human carbonic anhydrase II inhibition using topological indices and their combination with quantum-theoretical descriptors. Med Chem 4:30\u201366","journal-title":"Med Chem"},{"key":"832_CR41","doi-asserted-by":"publisher","first-page":"581","DOI":"10.2174\/157018012800673001","volume":"9","author":"SM Verma","year":"2012","unstructured":"Verma SM, Saha A, Mishra R, Sethi KK (2012) 3D-QSAR study of some heterocyclic sulfonamide analogs as hCAII inhibitors. Lett Drug Des Discov 9:581\u2013586","journal-title":"Lett Drug Des Discov"},{"key":"832_CR42","doi-asserted-by":"publisher","first-page":"1722","DOI":"10.1080\/14756366.2019.1670657","volume":"34","author":"S Bilginer","year":"2019","unstructured":"Bilginer S, Gul HI, Erdal FS, Sakagami H, Levent S, Gulcin I, Supuran CT, Synthesis (2019) Cytotoxicities, and carbonic anhydrase inhibition potential of 6-(3-Aryl-2-Propenoyl)-2(3H)-Benzoxazolones. J Enzym Inhib Med Chem 34:1722\u20131729. https:\/\/doi.org\/10.1080\/14756366.2019.1670657","journal-title":"J Enzym Inhib Med Chem"},{"key":"832_CR43","doi-asserted-by":"publisher","first-page":"5867","DOI":"10.1016\/j.bmcl.2016.11.017","volume":"26","author":"T Arslan","year":"2016","unstructured":"Arslan T, Turkoglu EA, Senturk M, Supuran CT (2016) Synthesis and carbonic anhydrase inhibitory properties of novel chalcone substituted benzenesulfonamides. Bioorg Med Chem Lett 26:5867\u20135870. https:\/\/doi.org\/10.1016\/j.bmcl.2016.11.017","journal-title":"Bioorg Med Chem Lett"},{"key":"832_CR44","doi-asserted-by":"publisher","first-page":"127868","DOI":"10.1016\/j.molstruc.2020.127868","volume":"1208","author":"S Burmaoglu","year":"2020","unstructured":"Burmaoglu S, Kazancioglu EA, Kaya R, Kazancioglu M, Karaman M, Algul O, Gulcin I (2020) Synthesis of novel organohalogen chalcone derivatives and screening of their molecular docking study and some enzymes inhibition effects. J Mol Struct 1208:127868. https:\/\/doi.org\/10.1016\/j.molstruc.2020.127868","journal-title":"J Mol Struct"},{"key":"832_CR45","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1016\/j.bioorg.2016.12.001","volume":"70","author":"UM Kocyigit","year":"2017","unstructured":"Kocyigit UM, Budak Y, Gurdere MB, Tekin S, Koprulu TK, Erturk F, Ozcan K, Gulcin I, Ceylan M (2017) Synthesis characterization, anticancer, antimicrobial and carbonic anhydrase inhibition profiles of novel (3aR,4S,7R,7aS)-2-(4-((E)-3-(3-Aryl)a Cryloyl) Phenyl)-3a,4,7,7a-Tetrahydro-1H-4,7-Methanoisoindole-1,3(2H)-Dione Derivatives. Bioorg Chem 70:118\u2013125. https:\/\/doi.org\/10.1016\/j.bioorg.2016.12.001","journal-title":"Bioorg Chem"},{"key":"832_CR46","doi-asserted-by":"publisher","first-page":"103095","DOI":"10.1016\/j.bioorg.2019.103095","volume":"90","author":"M Tugrak","year":"2019","unstructured":"Tugrak M, Gul HI, Bandow K, Sakagami H, Gulcin I, Ozkay Y, Supuran CT (2019) Synthesis and biological evaluation of some new mono mannich bases with piperazines as possible anticancer agents and carbonic anhydrase inhibitors. Bioorg Chem 90:103095. https:\/\/doi.org\/10.1016\/j.bioorg.2019.103095","journal-title":"Bioorg Chem"},{"key":"832_CR47","doi-asserted-by":"publisher","first-page":"103057","DOI":"10.1016\/j.bioorg.2019.103057","volume":"90","author":"HI Gul","year":"2019","unstructured":"Gul HI, Tugrak M, Gul M, Mazlumoglu S, Sakagami H, Gulcin I, Supuran CT (2019) New phenolic mannich bases with piperazines and their bioactivities. Bioorg Chem 90:103057. https:\/\/doi.org\/10.1016\/j.bioorg.2019.103057","journal-title":"Bioorg Chem"},{"key":"832_CR48","doi-asserted-by":"publisher","first-page":"103839","DOI":"10.1016\/j.bioorg.2020.103839","volume":"99","author":"P Singh","year":"2020","unstructured":"Singh P, Swain B, Thacker PS, Sigalapalli DK, Yadav PP, Angeli A, Supuran CT, Arifuddin M (2020) Synthesis and carbonic anhydrase inhibition studies of sulfonamide based indole-1,2,3-triazole chalcone hybrids. Bioorg Chem 99:103839. https:\/\/doi.org\/10.1016\/j.bioorg.2020.103839","journal-title":"Bioorg Chem"},{"key":"832_CR49","doi-asserted-by":"publisher","first-page":"e1900384","DOI":"10.1002\/ardp.201900384","volume":"353","author":"S Bilginer","year":"2020","unstructured":"Bilginer S, Gul HI, Erdal FS, Sakagami H, Gulcin I (2020) New halogenated chalcones with cytotoxic and carbonic anhydrase inhibitory properties: 6-(3-Halogenated Phenyl-2-Propen-1-Oyl)-2(3H)-benzoxazolones. Arch Pharm 353:e1900384. https:\/\/doi.org\/10.1002\/ardp.201900384","journal-title":"Arch Pharm"},{"key":"832_CR50","doi-asserted-by":"publisher","first-page":"e2000202","DOI":"10.1002\/ardp.202000202","volume":"353","author":"UM Kocyigit","year":"2020","unstructured":"Kocyigit UM, Gezegen H, Taslimi P, Synthesis (2020) Characterization and biological studies of chalcone derivatives containing schiff bases: synthetic derivatives for the treatment of epilepsy and alzheimer\u2019s disease. Arch Pharm 353:e2000202. https:\/\/doi.org\/10.1002\/ardp.202000202","journal-title":"Arch Pharm"},{"key":"832_CR51","doi-asserted-by":"publisher","first-page":"e22281","DOI":"10.1002\/jbt.22281","volume":"33","author":"U Tutar","year":"2019","unstructured":"Tutar U, Kocyigit UM, Gezegen H (2019) Evaluation of antimicrobial, antibiofilm and carbonic anhydrase inhibition profiles of 1,3-bis-chalcone derivatives. J Biochem Mol Toxicol 33:e22281. https:\/\/doi.org\/10.1002\/jbt.22281","journal-title":"J Biochem Mol Toxicol"},{"key":"832_CR52","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1080\/13813455.2017.1360914","volume":"124","author":"UM Kocyigit","year":"2018","unstructured":"Kocyigit UM, Budak Y, Gurdere MB, Erturk F, Yencilek B, Taslimi P, Gulcin I, Ceylan M (2018) Synthesis of chalcone-imide derivatives and investigation of their anticancer and antimicrobial activities, carbonic anhydrase and acetylcholinesterase enzymes inhibition profiles. Arch Physiol Biochem 124:61\u201368. https:\/\/doi.org\/10.1080\/13813455.2017.1360914","journal-title":"Arch Physiol Biochem"},{"key":"832_CR53","doi-asserted-by":"publisher","first-page":"404","DOI":"10.3390\/molecules22030404","volume":"22","author":"G Apablaza","year":"2017","unstructured":"Apablaza G, Montoya L, Morales-Verdejo C, Mellado M, Cuellar M, Lagos CF, Soto-Delgado J, Chung H, Pessoa-Mahana CD, Mella J (2017) 2D-QSAR and 3D-QSAR\/CoMSIA studies on a series of (R)-2-((2-(1H-Indol-2-Yl)Ethyl)Amino)-1-Phenylethan-1-Ol with Human \u03b23-adrenergic activity. Molecules 22:404. https:\/\/doi.org\/10.3390\/molecules22030404","journal-title":"Molecules"},{"key":"832_CR54","doi-asserted-by":"publisher","first-page":"532","DOI":"10.1002\/cmdc.202000018","volume":"15","author":"MJ Matos","year":"2020","unstructured":"Matos MJ, Herrera Ibat\u00e1 DM, Uriarte E, Vi\u00f1a D (2020) Coumarin-rasagiline hybrids as potent and selective hMAO-B inhibitors, antioxidants, and neuroprotective agents. ChemMedChem 15:532\u2013538. https:\/\/doi.org\/10.1002\/cmdc.202000018","journal-title":"ChemMedChem"},{"key":"832_CR55","doi-asserted-by":"publisher","first-page":"103964","DOI":"10.1016\/j.bioorg.2020.103964","volume":"101","author":"M Mellado","year":"2020","unstructured":"Mellado M, Mella J, Gonzalez C, Vina D, Uriarte E, Matos MJ (2020) 3-arylcoumarins as highly potent and selective monoamine oxidase B inhibitors: which chemical features matter?. Bioorg Chem 101:103964. https:\/\/doi.org\/10.1016\/j.bioorg.2020.103964","journal-title":"Bioorg Chem"},{"key":"832_CR56","doi-asserted-by":"publisher","first-page":"4130","DOI":"10.1021\/jm00050a010","volume":"37","author":"G Klebe","year":"1994","unstructured":"Klebe G, Abraham U, Mietzner T (1994) Molecular similarity indices in a comparative analysis (CoMSIA) of drug molecules to correlate and predict their biological activity. J Med Chem 37:4130\u20134146. https:\/\/doi.org\/10.1021\/jm00050a010","journal-title":"J Med Chem"},{"key":"832_CR57","doi-asserted-by":"publisher","first-page":"982","DOI":"10.1002\/jcc.540100804","volume":"10","author":"M Clark","year":"1989","unstructured":"Clark M, Cramer R, Vanopdenbosch N (1989) Validation of the general-purpose tripos 5.2 force-field. J Comput Chem 10:982\u20131012. https:\/\/doi.org\/10.1002\/jcc.540100804","journal-title":"J Comput Chem"},{"key":"832_CR58","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.chemolab.2015.04.013","volume":"145","author":"K Roy","year":"2015","unstructured":"Roy K, Kar S, Ambure P (2015) On a simple approach for determining applicability domain of QSAR models. Chemometrics Intell Lab Syst 145:22\u201329. https:\/\/doi.org\/10.1016\/j.chemolab.2015.04.013","journal-title":"Chemometrics Intell Lab Syst"},{"key":"832_CR59","doi-asserted-by":"publisher","first-page":"1449","DOI":"10.1007\/s10895-022-02941-2","volume":"32","author":"M Mellado","year":"2022","unstructured":"Mellado M, Roldan N, Miranda R, Aguilar LF, Bravo MA, Quiroz W (2022) Sensitive fluorescent chemosensor for Hg(II) in aqueous solution using 4\u2019-Dimethylaminochalcone. J Fluoresc 32:1449\u20131456. https:\/\/doi.org\/10.1007\/s10895-022-02941-2","journal-title":"J Fluoresc"},{"key":"832_CR60","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1021\/ct100578z","volume":"7","author":"MHM Olsson","year":"2011","unstructured":"Olsson MHM, S\u00f8ndergaard CR, Rostkowski M, Jensen JH (2011) PROPKA3: consistent treatment of internal and surface residues in empirical p K a predictions. J Chem Theory Comput 7:525\u2013537. https:\/\/doi.org\/10.1021\/ct100578z","journal-title":"J Chem Theory Comput"},{"key":"832_CR61","doi-asserted-by":"publisher","first-page":"2284","DOI":"10.1021\/ct200133y","volume":"7","author":"CR S\u00f8ndergaard","year":"2011","unstructured":"S\u00f8ndergaard CR, Olsson MHM, Rostkowski M, Jensen JH (2011) Improved treatment of ligands and coupling effects in empirical calculation and rationalization of p K a values. J Chem Theory Comput 7:2284\u20132295. https:\/\/doi.org\/10.1021\/ct200133y","journal-title":"J Chem Theory Comput"},{"key":"832_CR62","doi-asserted-by":"publisher","first-page":"1605","DOI":"10.1002\/jcc.20084","volume":"25","author":"EF Pettersen","year":"2004","unstructured":"Pettersen EF, Goddard TD, Huang CC, Couch GS, Greenblatt DM, Meng EC, Ferrin TE (2004) UCSF chimera\u2014a visualization system for exploratory research and analysis. J Comput Chem 25:1605\u20131612. https:\/\/doi.org\/10.1002\/jcc.20084","journal-title":"J Comput Chem"},{"key":"832_CR63","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1016\/j.jmgm.2005.12.005","volume":"25","author":"J Wang","year":"2006","unstructured":"Wang J, Wang W, Kollman PA, Case DA (2006) Automatic atom type and bond type perception in molecular mechanical calculations. J Mol Graph Model 25:247\u2013260. https:\/\/doi.org\/10.1016\/j.jmgm.2005.12.005","journal-title":"J Mol Graph Model"},{"key":"832_CR64","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1002\/jcc.21334","volume":"31","author":"O Trott","year":"2010","unstructured":"Trott O, Olson AJ (2010) Software news and update autodock vina: improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading. J Comput Chem 31:455\u2013461. https:\/\/doi.org\/10.1002\/jcc.21334","journal-title":"J Comput Chem"},{"key":"832_CR65","doi-asserted-by":"publisher","first-page":"3891","DOI":"10.1021\/acs.jcim.1c00203","volume":"61","author":"J Eberhardt","year":"2021","unstructured":"Eberhardt J, Santos-Martins D, Tillack AF, Forli S (2021) AutoDock Vina 1.2.0: new docking methods, expanded force field, and python bindings. J Chem Inf Model 61:3891\u20133898. https:\/\/doi.org\/10.1021\/acs.jcim.1c00203","journal-title":"J Chem Inf Model"},{"key":"832_CR66","unstructured":"Syst\u00e8mes BIOVIAD (2021) Discovery studio modeling environment, Release 2021; Dassault Syst\u00e8mes: San Diego, CA, USA"},{"key":"832_CR67","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1002\/pro.3943","volume":"30","author":"EF Pettersen","year":"2021","unstructured":"Pettersen EF, Goddard TD, Huang CC, Meng EC, Couch GS, Croll TI, Morris JH, Ferrin TE (2021) UCSF ChimeraX: structure visualization for researchers, educators, and developers. Protein Sci 30:70\u201382. https:\/\/doi.org\/10.1002\/pro.3943","journal-title":"Protein Sci"},{"key":"832_CR68","unstructured":"Chow E, Rendleman C, Bowers K, Dror R, Gullingsrud J, Sacerdoti FD, Shaw D (2008) Desmond performance on a cluster of multicore processors. D. E. Shaw Research Technical Report DESRES\/TR-2008-01, New York. http:\/\/deshawresearch.com http:\/\/deshawresearch.com"},{"key":"832_CR69","doi-asserted-by":"crossref","unstructured":"Bowers KJ, Chow DE, Xu H, Dror RO, Eastwood MP, Gregersen BA, Klepeis JL, Kolossvary I, Moraes MA, Sacerdoti FD et al (2006) November. scalable algorithms for molecular dynamics simulations on commodity clusters. In: Proceedings of the SC \u201906: Proceedings of the 2006 ACM\/IEEE Conference on Supercomputing; ; pp. 43\u201343","DOI":"10.1109\/SC.2006.54"},{"key":"832_CR70","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1002\/prot.10613","volume":"55","author":"MP Jacobson","year":"2004","unstructured":"Jacobson MP, Pincus DL, Rapp CS, Day TJF, Honig B, Shaw DE, Friesner RA (2004) A hierarchical approach to all-atom protein loop prediction. Proteins 55:351\u2013367. https:\/\/doi.org\/10.1002\/prot.10613","journal-title":"Proteins"},{"key":"832_CR71","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/07391102.2023.2172457","volume":"0","author":"D Cabezas","year":"2023","unstructured":"Cabezas D, Mellado G, Espinoza N, G\u00e1rate JA, Morales C, Castro-Alvarez A, Matos MJ, Mellado M, Mella J (2023) In silico approaches to develop new phenyl-pyrimidines as glycogen synthase kinase 3 (GSK-3) inhibitors with halogen-bonding capabilities: 3D-QSAR CoMFA\/CoMSIA, molecular docking and molecular dynamics studies. J Biomol Struct Dynamics 0:1\u201310. https:\/\/doi.org\/10.1080\/07391102.2023.2172457","journal-title":"J Biomol Struct Dynamics"},{"key":"832_CR72","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1021\/ci0342472","volume":"44","author":"DM Hawkins","year":"2004","unstructured":"Hawkins DM (2004) The problem of overfitting. J Chem Inf Comput Sci 44:1\u201312. https:\/\/doi.org\/10.1021\/ci0342472","journal-title":"J Chem Inf Comput Sci"},{"key":"832_CR73","doi-asserted-by":"publisher","first-page":"1238","DOI":"10.1021\/jm00196a017","volume":"22","author":"J Topliss","year":"1979","unstructured":"Topliss J, Edwards R (1979) Chance factors in studies of quantitative structure-activity-relationships. J Med Chem 22:1238\u20131244. https:\/\/doi.org\/10.1021\/jm00196a017","journal-title":"J Med Chem"},{"key":"832_CR74","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1016\/S1093-3263(01)00123-1","volume":"20","author":"A Golbraikh","year":"2002","unstructured":"Golbraikh A, Tropsha A (2002) Beware of q <\u2009SUP>2! J Mol Graph 20:269\u2013276. https:\/\/doi.org\/10.1016\/S1093-3263(01)00123-1","journal-title":"J Mol Graph"},{"key":"832_CR75","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1002\/minf.201000061","volume":"29","author":"A Tropsha","year":"2010","unstructured":"Tropsha A (2010) Best practices for QSAR model development, validation, and exploitation. Mol Inf 29:476\u2013488. https:\/\/doi.org\/10.1002\/minf.201000061","journal-title":"Mol Inf"},{"key":"832_CR76","doi-asserted-by":"publisher","first-page":"1071","DOI":"10.1002\/jcc.23231","volume":"34","author":"K Roy","year":"2013","unstructured":"Roy K, Chakraborty P, Mitra I, Ojha PK, Kar S, Das RN (2013) Some case studies on application of r(m)(2) metrics for judging quality of quantitative structure-activity relationship predictions: emphasis on scaling of response data. J Comput Chem 34:1071\u20131082. https:\/\/doi.org\/10.1002\/jcc.23231","journal-title":"J Comput Chem"},{"key":"832_CR77","doi-asserted-by":"publisher","first-page":"2345","DOI":"10.1021\/ci700157b","volume":"47","author":"C Ruecker","year":"2007","unstructured":"Ruecker C, Ruecker G, Meringer MY (2007) -Randomization and its variants in QSPR\/QSAR. J Chem Inf Model 47:2345\u20132357. https:\/\/doi.org\/10.1021\/ci700157b","journal-title":"J Chem Inf Model"}],"container-title":["Journal of Computer-Aided Molecular Design"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10822-026-00832-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10822-026-00832-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10822-026-00832-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T05:01:18Z","timestamp":1778734878000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10822-026-00832-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,14]]},"references-count":77,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["832"],"URL":"https:\/\/doi.org\/10.1007\/s10822-026-00832-3","relation":{},"ISSN":["1573-4951"],"issn-type":[{"value":"1573-4951","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,14]]},"assertion":[{"value":"1 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"123"}}